Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/18/2014US8889038 Wood preservatives containing copper complexes
11/18/2014US8888761 Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
11/18/2014US8888736 High shear application in medical therapy
11/13/2014US20140336571 Compositions and methods for delivery of hydrophobic active agents
11/13/2014US20140336440 Inhibitors of rho associated protein kinases (rock) and methods of use
11/13/2014US20140336386 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
11/13/2014US20140336278 In Situ Gelling Drug Delivery System
11/13/2014US20140336274 Process for producing inorganic particulate material
11/13/2014US20140336272 Petrolatum Composition
11/13/2014US20140336270 Method for synthesizing (E)-Anethol and Related Compounds By Cross Coupling Reaction of Potassium allyltrifluroborate and 4-bromoanisole and aryl halides
11/13/2014US20140336268 Formulations of vitamin k analogs for topical use
11/13/2014US20140336267 Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
11/13/2014US20140336266 Method for administering an nmda receptor antagonist to a subject
11/13/2014US20140336264 Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
11/13/2014US20140336258 Anti-virulence compositions and methods
11/13/2014US20140336257 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
11/13/2014US20140336256 Method of treating tourette's disorder with gaba-aminotransferase inactivators
11/13/2014US20140336253 Composition for transdermal administration of rivastigmine
11/13/2014US20140336251 Methods of treating age related disorders
11/13/2014US20140336250 Method for treating bronchial diseases
11/13/2014US20140336248 Therapeutic compositions and related methods of use
11/13/2014US20140336243 Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
11/13/2014US20140336240 Method of treating hyperlipidemia and atherosclerosis with mir-30c
11/13/2014US20140336236 Novel alk and ntrk1 fusion molecules and uses thereof
11/13/2014US20140336234 CHLOROPHYLL c CONTAINING DEGRANULATION SUPPRESSOR
11/13/2014US20140336230 Method of increasing metabolism
11/13/2014US20140336229 Pharmaceutical composition for preventing or treating hyperlipidemia
11/13/2014US20140336228 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
11/13/2014US20140336227 3-amino lactams as anti-inflammatory agents
11/13/2014US20140336226 Salt Of (R)-3-(6-Amino-Pyridin-3-Yl)-2-(1-Cyclohexyl-1H-Imidazol-4-Yl) Ethyl Propionate
11/13/2014US20140336224 Mineralocorticoid receptor antagonists
11/13/2014US20140336223 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
11/13/2014US20140336220 Composition for preventing or treating obesity comprising rebamipide
11/13/2014US20140336218 Arformoterol and tiotropium compositions and methods for use
11/13/2014US20140336216 Physiological ligands for gpr139
11/13/2014US20140336215 Rhinitis Treatment Regimens
11/13/2014US20140336214 Compositions, Dosage Forms, and Co-Administration of an Opioid Agonist Compound and an Analgesic Compound
11/13/2014US20140336213 Abuse Deterrent Compositions and Methods of Making Same
11/13/2014US20140336212 Combination Analgesic Employing Opioid Agonist and Neutral Antagonist
11/13/2014US20140336210 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/13/2014US20140336205 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use
11/13/2014US20140336204 Methods of inhibiting xanthine oxidase activity in a cell
11/13/2014US20140336202 Methods of identifying and using mdm2 inhibitors
11/13/2014US20140336201 Bipyridyl derivatives
11/13/2014US20140336194 Method of treating contrast-induced nephropathy
11/13/2014US20140336192 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
11/13/2014US20140336185 Novel glp-1 receptor stabilizers and modulators
11/13/2014US20140336183 Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury
11/13/2014US20140336180 Combination of mek inhibitors and selective inhibitors of aurora a kinase
11/13/2014US20140336178 Compositions and methods for modulating interaction between polypeptides
11/13/2014US20140336177 Inhibitors of the renal outer medullary potassium channel
11/13/2014US20140336173 Disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336171 Azaindoles useful as inhibitors of janus kinases
11/13/2014US20140336168 Nampt inhibitors
11/13/2014US20140336166 Novel purine derivatives and their use in the treatment of disease
11/13/2014US20140336164 Biodegradable non-ophthalmic implants and related methods
11/13/2014US20140336163 Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
11/13/2014US20140336162 Locally administrated low doses of corticosteroids
11/13/2014US20140336161 Pharmaceutical formulations containing corticosteroids for topical administration
11/13/2014US20140336159 Methods for treating and diagnosing respiratory tract infections
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140336157 Methods and compositions for treating cancer
11/13/2014US20140336150 Administration of Karenitecin for the Treatment of Platinum and/or Taxane Chemotherapy-Resistant or -Refractory Advanced Ovarian Cancer
11/13/2014US20140336149 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
11/13/2014US20140336148 Combinations of diacerein and non-steroidal inflammation drugs
11/13/2014US20140336147 Hemostatic agents and methods of use
11/13/2014US20140336145 Compositions and methods for treating oculopharyngeal muscular dystrophy
11/13/2014US20140336144 External Preparation Containing NSAIDS And Method For Producing The External Preparation
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140336142 Method For Treatment Of Macular Degeneration By Modulating P2Y12 or P2X7 Receptors
11/13/2014US20140336141 Mao-b inhibitors derived from the one-carbon cycle
11/13/2014US20140336140 Methods for providing sialylated oligosaccharides
11/13/2014US20140336139 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
11/13/2014US20140336138 Compositions and methods for screening and treatment of sturge-weber syndrome, klippel-trenaunay-weber syndrome, and port-wine stains (pwss)
11/13/2014US20140336135 Novel use of rhododendrin
11/13/2014US20140336131 Methods for treating inflammation, autoimmune disorders and pain
11/13/2014US20140336129 Targeting the EGFR-SGLT1 Interaction for Cancer Therapy
11/13/2014US20140336120 Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury
11/13/2014US20140336113 Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome
11/13/2014US20140336111 Therapeutic Use of Activators of Zinc Finger Protein GL13
11/13/2014US20140335210 Method and agrochemical composition for using larch wood extracts in agriculture
11/13/2014US20140335208 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells
11/13/2014US20140335206 Topical analgesic composition
11/13/2014US20140335205 Materials and methods for treatment of disorders associated with oxidative stress
11/13/2014US20140335198 Stable bicarbonate ion-containing drug solution
11/13/2014US20140335194 Polymeric nanoparticle solution composition and its manufacturing process
11/13/2014US20140335193 Controlled-release injectable microparticle
11/13/2014US20140335191 Compositions and methods for enhancing brain function
11/13/2014US20140335190 New non-abusable pharmaceutical composition comprising opioids
11/13/2014US20140335186 Methods and compositions for enhancing cd4+ regulatory t cells
11/13/2014US20140335184 Nanoparticle assembly, preparation thereof, and active material delivering composite comprising the same
11/13/2014US20140335181 Dry coated tablet
11/13/2014US20140335178 Dosage forms of apixaban
11/13/2014US20140335177 Pharmaceutical composition
11/13/2014US20140335176 Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing
11/13/2014US20140335175 Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
11/13/2014US20140335174 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
11/13/2014US20140335172 Ophthalmological rinsing agent and methods therefof
11/13/2014US20140335171 Stable Formulations of Antiplatelet Agents, Omega-3 Fatty Acids and Amylose In Soft Gelatin Capsules
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 7860